Works matching IS 11782595 AND DT 2021 AND VI 35 AND IP 4
Results: 7
Clinical Quality in Cancer Research: Strategy to Assess Data Integrity of Germline Variants Inferred from Tumor-Only Testing Sequencing Data.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 225, doi. 10.1007/s40290-021-00399-4
- By:
- Publication type:
- Article
The Emergency Use Authorization of Pharmaceuticals: History and Utility During the COVID-19 Pandemic.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 203, doi. 10.1007/s40290-021-00397-6
- By:
- Publication type:
- Article
Biosimilar Uptake: The Importance of Healthcare Provider Education.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 215, doi. 10.1007/s40290-021-00396-7
- By:
- Publication type:
- Article
Challenges Faced by the Biopharmaceutical Industry in the Development and Marketing Authorization of Biosimilar Medicines in BRICS-TM Countries: An Exploratory Study.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 235, doi. 10.1007/s40290-021-00395-8
- By:
- Publication type:
- Article
Major Pharmaceutical Conferences and Courses: October to November 2021.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 261, doi. 10.1007/s40290-021-00394-9
- Publication type:
- Article
Evaluation of Drug Lags in Development Initiation, New Drug Application and Approval Between Japan and the USA and the Impact of Local Versus Multi-regional Clinical Trials.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 253, doi. 10.1007/s40290-021-00393-w
- By:
- Publication type:
- Article
Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic.
- Published in:
- Pharmaceutical Medicine, 2021, v. 35, n. 4, p. 197, doi. 10.1007/s40290-021-00392-x
- By:
- Publication type:
- Article